Bit & Bridle

Equine Neonatal Isoerythrolysis (NI)

Other Names

  • NI
  • Haemolytic icterus of newborn foals
  • Jaundice foal syndrome

What is Equine Neonatal Isoerythrolysis (NI)?

Equine Neonatal Isoerythrolysis (NI) is a potentially fatal blood condition affecting newborn foals in which antibodies from the mare’s colostrum destroy the foal’s red blood cells. It is an immune-mediated haemolytic anaemia: the mare produces antibodies against specific red blood cell antigens present on the foal’s erythrocytes (inherited from the sire), and when the foal ingests colostrum after birth, these antibodies are absorbed through the gut wall and attack the foal’s own red blood cells.

NI is a classic example of maternal alloimmunisation, and while it is uncommon, it is life-threatening when it does occur. Affected foals appear normal at birth but rapidly deteriorate within hours to days as red blood cell destruction (haemolysis) accelerates. Without prompt diagnosis and treatment, severely affected foals can die within 24–72 hours.

Causes

NI occurs through a specific sequence of immunological events:

  1. The foal inherits red blood cell surface antigens from the sire that are absent on the mare’s erythrocytes.
  2. During a previous pregnancy, birth, or through some other sensitising event, the mare was exposed to these foreign antigens and produced alloantibodies against them.
  3. These antibodies concentrate in the colostrum (first milk).
  4. After birth, the foal ingests colostrum and absorbs the antibodies through the highly permeable neonatal gut.
  5. The absorbed antibodies bind to the foal’s red blood cells and trigger immune-mediated haemolysis.

The most important blood group antigens involved are the Aa and Qa factors in horses. Thoroughbred mares and mares with known sensitisation history are at higher risk. Mares that have previously produced an NI foal are at significantly elevated risk in subsequent pregnancies.

Symptoms and Signs

Foals with NI are typically normal at birth and during the first hours of life, as haemolysis requires the colostrum to be absorbed:

  • Progressive lethargy and weakness — usually apparent within 12–36 hours of birth
  • Rapid heart rate (tachycardia) and increased respiratory rate
  • Pale, white, or jaundiced (icteric) mucous membranes
  • Yellow discolouration of the sclerae (whites of the eyes) and skin
  • Dark (red-brown or orange) urine — due to haemoglobinuria
  • Weakness, ataxia, or inability to stand
  • Yawning, seizures, or other neurological signs in severe anaemia
  • Death in untreated severe cases

Diagnosis

  • Clinical signs: The characteristic progression from a normal foal to a rapidly deteriorating, jaundiced, weak foal within 24–72 hours of birth is highly suggestive.
  • Blood smear: May reveal spherocytes or other signs of immune-mediated red cell destruction.
  • Packed cell volume (PCV) / haematocrit: A rapidly falling PCV in a neonatal foal confirms haemolysis. PCV below 12–15% is considered critically low.
  • Jaundice testing: The Coggins-style jaundice agglutination test or cross-matching of foal blood with mare’s colostrum or serum can confirm NI. A positive agglutination reaction confirms incompatibility.
  • Blood typing and cross-matching: Definitive identification of incompatible blood groups.

Treatment

Early intervention is critical:

  • Prevent further colostrum ingestion: If NI is suspected early, the foal must be muzzled and separated from the mare immediately to prevent further antibody absorption. The mare’s milk should be stripped out and discarded every 2 hours during this period.
  • Alternative colostrum: The foal still requires passive immune transfer — colostrum from a compatible donor mare (blood-typed as negative for the offending antigen) should be sourced urgently, or commercial equine plasma used for IV administration.
  • Intravenous fluids: To support circulation and renal function during haemolysis.
  • Blood transfusion: Required in moderate to severe cases (PCV below 12%). The mare’s own washed red blood cells (antibodies removed) are the safest donor source; alternatively, a compatible donor horse that has been cross-matched.
  • Corticosteroids: May be used to reduce immune-mediated haemolysis in some cases.
  • Supportive care: Warmth, nutrition support, and treatment of secondary complications.

Once the foal’s gut closes (around 24–36 hours of age), antibody absorption ceases and the mare’s milk can be reintroduced safely.

Prevention

  • Identify at-risk mares before foaling — particularly mares with a history of NI foals or mares known to have blood type incompatibilities with their mate.
  • Blood type the mare and stallion before breeding; avoid pairings where foal antigen incompatibility is likely.
  • Test late-term colostrum from at-risk mares using a jaundice foal agglutination kit — widely available for in-field use.
  • Have a plan in place before the at-risk foal is born: source compatible donor colostrum or commercial equine plasma in advance.
  • Muzzle newborn foals from at-risk mares until testing confirms compatibility.

Prognosis

Mildly to moderately affected foals that receive prompt treatment, including cessation of colostrum feeding and blood transfusion if required, carry a good to excellent prognosis. Severely affected foals — particularly those with PCV below 8% or significant neurological signs — have a more guarded prognosis. The key determinant of outcome is how quickly the condition is recognised and treated.

When to Call the Vet

Contact your vet immediately if a newborn foal:

  • Becomes progressively weak or lethargic within the first 24–48 hours after birth
  • Has pale, white, or yellow (jaundiced) mucous membranes
  • Is passing dark-coloured urine
  • Has yellow-tinged eyes or skin

NI is a neonatal emergency — every hour counts.

Frequently Asked Questions

Can NI affect a first foal?

It is unusual but possible. A first foal can be affected if the mare was sensitised to red blood cell antigens by a previous blood transfusion rather than a prior pregnancy. More typically, NI occurs in second or subsequent foals after the mare has been sensitised during a previous pregnancy.

Is NI the same in horses as Rh disease in humans?

The mechanism is very similar — in both cases, maternal alloantibodies cross to the offspring and destroy their red blood cells. The specific antigens involved differ (Aa and Qa in horses vs RhD in humans), but the underlying immunological process is analogous.

How quickly does a foal with NI deteriorate?

This depends on the severity of the incompatibility and how much colostrum was ingested. Some foals deteriorate rapidly within 12–18 hours; others decline more gradually over two to three days. Any neonatal foal showing progressive weakness and jaundice should be assessed as an emergency.

Can the same mare produce NI foals in subsequent pregnancies?

Yes — once sensitised, a mare remains at risk for all subsequent foals by stallions carrying the incompatible antigen. Careful pre-breeding blood typing and colostrum testing before each foaling is essential for previously affected mares.